Conference
Phase II study of sorafenib (BAY 43-9006) in combination with gemcitabine in recurrent epithelial ovarian cancer: A PMH phase II consortium trial.
Authors
Welch S; Hirte H; Schilder RJ; Elit L; Townsley C; Tinker L; Pond G; Afinec A; Wright JJ; Oza AM
Volume
24
Pagination
pp. 276S-276S
Publisher
AMER SOC CLINICAL ONCOLOGY
Publication Date
June 20, 2006
Name of conference
42nd Annual Meeting of the American-Society-of-Clinical-Oncology
Conference place
Atlanta, GA
Conference start date
June 2, 2006
Conference end date
June 6, 2006
Conference proceedings
JOURNAL OF CLINICAL ONCOLOGY
Issue
18
ISSN
0732-183X